Novel Novartis Malaria Drug Shows Promise to Become New Asset Against Resistant Strains
Malaria leads to nearly 600,000 deaths annually, but that figure was closer to 2 million a quarter century ago. Deaths ...
Sunday, December 14, 2025
Tag: Novartis
Novartis Continues RNA & Neuroscience Growth Strategy With $12B Avidity Bio Acquisition
Novartis has made RNA medicines one of its top strategic goals and it already has RNA therapies for cardiovascular indications. ...
With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen
Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings ...
Novartis Tries Again in Parkinson’s, Putting Up $200M for Arrowhead’s RNAi Therapy
Parkinson’s disease is associated with the buildup of a particular brain protein that currently has no approved therapies addressing it. ...
Alphabet’s Isomorphic labs to collaborate with Novartis, Lilly on AI-driven drug discovery
Bloomberg—Isomorphic Labs, a subsidiary of Alphabet Inc., said it entered into strategic research collaboration agreements with Novartis AG and Eli ...